Results 81 to 90 of about 482,990 (203)
Evolving drug therapies for chronic hepatitis C: Immunomodulation and beyond [PDF]
, 2011 Chronic hepatitis C infection is a major health problem and a leading cause of chronic liver disease. The hepatitis C virus was discovered in 1989 (1, 2).
Bergmann, J.F. (Jilling)
core
Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature [PDF]
, 2006 An association between chronic hepatitis C virus (HCV) infection and essential mixed cryoglobulinaemia and non-Hodgkin lymphoma (NHL) has been suggested. However, a causative role of HCV in these conditions has not been established.
Abonyi, Margit E. +4 more
core +1 more source
КЛИНИКО-ЛАБОРАТОРНАЯ ХАРАКТЕРИСТИКА ХРОНИЧЕСКИХ ГЕПАТИТОВ И ЦИРРОЗОВ ПЕЧЕНИ РАЗЛИЧНОЙ ЭТИОЛОГИИ
Архивъ внутренней медицины, 2015 The review of literature discusses the clinical and biochemical changes in patients with chronic hepatitis C, chronic hepatitis of alcoholic etiology, chronic hepatitis combined genesis (HCV + alcohol) and cirrhosis in the outcome of hepatitis, liver ...
А. Р. Билалова +1 more
doaj +1 more source
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic hepatitis C virus infection [PDF]
, 2015 CD8(+) T cells specific to caspase-cleaved antigens derived from apoptotic T cells represent a principal player in chronic immune activation (CIA). Here, we found that both apoptotic epitope (AE)-specific and hepatitis C virus (HCV)-specific CD8(+) T ...
Accapezzato, Daniele +18 more
core +1 more source
Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C. [PDF]
, 2015 Sofosbuvir and simeprevir are used for the treatment of chronic hepatitis C (HCV) genotype 1. Both drugs have been well-tolerated, with diarrhea noted in 6% cases with sofosbuvir, 16% with sofosbuvir plus simeprevir, and 0% with simeprevir.
Jakab, Simona +4 more
core +1 more source
Bicyclol for chronic hepatitis C
Cochrane Database of Systematic Reviews, 2007 Bicyclol is a novel synthetic 'anti-hepatitis' drug, used in China for chronic hepatitis C. Until now, systematic reviews on bicyclol therapy have not been performed.To study the benefits and harms of bicyclol for patients with chronic hepatitis C.We searched The Cochrane Hepato-Biliary Group Controlled Trials Register (July 2005), the Cochrane Central
Yang, Xiaoyan +3 more
openaire +2 more sources
Aktualʹnaâ Infektologiâ, 2014 The use of combination antiviral therapy enables to achieve sustained virologic response in patients with chronic hepatitis C, but in some patients side effects occur during treatment.
D.V. Dontsov +7 more
doaj +1 more source
The Role of Specific Cellular Immune System in Chronic Hepatitis C [PDF]
, 2004 Hepatitis C virus is a RNA virus with very high speed replication. The clinical course of chronic hepatitis C is frequently asymptomatic like other hepatitis viruses.
Akbar, N. (Nurul) +4 more
core +1 more source
Asthenia in Children with Chronic Viral Hepatitis
Zdorovʹe Rebenka, 2015 In the article results of own researches concerning peculiarities of the course of asthenic syndrome in school-aged children with chronic hepatitis B, C and mixed forms are provided. It is established that chronic hepatitis C as well as a mixed hepatitis
I.S. Lembryk
doaj +1 more source
مجله دانشکده پزشکی اصفهان, 2011 The five known causes of acute hepatitis are the hepatitis A (HAV), B (HBV), C (HCV), D (HDV), and E (HEV) viruses. Hepatitis A and E are forms of infectious hepatitis which spread largely by the fecal-oral route, occur in outbreaks a well as ...
Hamid kalantari
doaj